Physical activity for patients with heart failure: Position paper from the heart failure (GICC) and cardiac rehabilitation (GERS-P) Working Groups of the French Society of Cardiology

Arch Cardiovasc Dis. 2019 Nov;112(11):723-731. doi: 10.1016/j.acvd.2019.07.003. Epub 2019 Sep 18.

Abstract

Physical activity is important in heart failure to improve functional capacity, quality of life and prognosis, and is a class IA recommendation in the European Society of Cardiology guidelines (Ponikowski et al., 2016). The benefits of exercise training are widely recognized. Cardiac rehabilitation centres offer tailored exercise training to patients with heart failure, as part of specialized multidisciplinary care, alongside pharmacological treatment optimization and patient education. After cardiac rehabilitation, maintenance of regular physical activity long term is essential, as the benefits of exercise training vanish within a few weeks. Unfortunately, only 10% of patients benefit from a cardiac rehabilitation programme after hospitalization for acute heart failure, and the majority of patients do not pursue long-term physical activity. In this paper, two Working Groups of the French Society of Cardiology (the heart failure group [Groupe Insuffisance Cardiaque et Cardiomyopathies; GICC] and the cardiac rehabilitation group [Groupe Exercice Réadaptation Sport et Prévention; GERS-P]) discuss the obstacles to broader access to cardiac rehabilitation centres, and propose ways to improve the diffusion of cardiac rehabilitation programmes and encourage long-term adherence to physical activity.

Keywords: Cardiac rehabilitation; Exercice; Exercise; Heart failure; Insuffisance cardiaque; Quality of life; Qualité de vie; Réadaptation cardiaque.

Publication types

  • Practice Guideline

MeSH terms

  • Cardiac Rehabilitation / adverse effects
  • Cardiac Rehabilitation / standards*
  • Consensus
  • Exercise Therapy / adverse effects
  • Exercise Therapy / standards*
  • Exercise Tolerance
  • France
  • Heart Failure / diagnosis
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Humans
  • Patient Compliance
  • Quality of Life
  • Recovery of Function
  • Time Factors
  • Treatment Outcome